Liberator Medical Holdings Now Covered by Analysts at Dawson James (LBMH)
Investment analysts at Dawson James initiated coverage on shares of Liberator Medical Holdings (NASDAQ:LBMH) in a note issued to investors on Monday, AmericanBankingNews.com reports. The firm set a “buy” rating and a $8.00 price target on the stock. Dawson James’ price target would indicate a potential upside of 86.05% from the company’s current price.
In other Liberator Medical Holdings news, major shareholder Millennium Partners, L.P. unloaded 100,000 shares of the stock on the open market in a transaction that occurred on Tuesday, December 24th. The stock was sold at an average price of $4.36, for a total value of $436,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Liberator Medical Holdings (NASDAQ:LBMH) remained flat at $4.30 during trading on Monday. 50,214 shares of the company’s stock traded hands. Liberator Medical Holdings has a one year low of $0.70 and a one year high of $4.60. The stock’s 50-day moving average is $3.62 and its 200-day moving average is $2.27. The company has a market cap of $225.3 million and a P/E ratio of 30.71.
Liberator Medical Holdings, Inc is a national direct-to-consumer provider of medical supplies to Medicare-eligible seniors.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.